Bruce Walcheck

11PUBLICATIONS
29CO-AUTHORS
Innate immunityMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 27, 2026
Next-Generation Multi-Engager Complexes Linking Natural Killer Cells to Tumor Cells and Targeting the Proteolytic Checkpoint ADAM17.

|Jul 25, 2024
Enhanced IL-15-mediated NK cell activation and proliferation by an ADAM17 function-blocking antibody involves CD16A, CD137, and accessory cells.

Anders W Matson, Rob Hullsiek, Kate J Dixon

|Dec 06, 2023
iPSC-derived natural killer cells expressing the FcγR fusion CD64/16A can be armed with antibodies for multitumor antigen targeting.

Kristin M Snyder, Kate J Dixon, Zachary Davis

|Jul 25, 2023
Detection of Antibody-Dependent Cell-Mediated Cytotoxicity-Supporting Antibodies by NK-92-CD16A Cell Externalization of CD107a: Recognition of Antibody Afucosylation and Assay Optimization.

Judith Cruz Amaya, Bruce Walcheck, Julie Smith-Gagen

|Mar 07, 2023
Ablation of SYK Kinase from Expanded Primary Human NK Cells via CRISPR/Cas9 Enhances Cytotoxicity and Cytokine Production.

James D Dahlvang, Jenna K Dick, Jules A Sangala

|Aug 02, 2022
Dual antigen-targeted off-the-shelf NK cells show durable response and prevent antigen escape in lymphoma and leukemia.

Frank Cichocki, Jodie P Goodridge, Ryan Bjordahl

Pageof 2

Frequent Collaborators

2 joint publications

Martin Felices

1 joint publications

Hallie M Hintz

1 joint publications

Kristin M Snyder

1 joint publications

Elisa C Toffoli